Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey
-
Pozo-Rosich, Patricia (Universitat Autònoma de Barcelona)
;
Gil-Gouveia, Raquel (Hospital da Luz (Lisboa, Portugal)) ;
Donnet, Anne (Timone Hospital) ;
Poole, Anne-Christine (Private Practice: Oslo Headache Centre) ;
Gendolla, Astrid (Private Practice: Essen) ;
Afridi, Shazia (Guy's and St Thomas' NHS Trust) ;
Sanchez-De la Rosa, Rainel (Novartis Pharma AG) ;
Terwindt, Gisela M. (Leiden University Medical Center) ;
Tassorelli, Cristina (University of Pavia)
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
